Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Secukinumab and ustekinumab treatment in psoriatic arthritis: results of a direct comparison.
Letarouilly JG, Flachaire B, Labadie C, Kyheng M, Cohen N, Sellam J, Richette P, Dieude P, Claudepierre P, Fautrel B, Houvenagel E, Nguyen CD, Guyot MH, Segaud N, Marguerie L, Deprez X, Salmon JH, Baudens G, Miceli-Richard C, Gervais E, Chary-Valckenaere I, Lafforgue P, Philippe P, Loeuille D, Richez C, Tubach F, Pham T, Flipo RM. Letarouilly JG, et al. Among authors: salmon jh. Rheumatology (Oxford). 2021 Jun 18;60(6):2773-2782. doi: 10.1093/rheumatology/keaa710. Rheumatology (Oxford). 2021. PMID: 33232465
Predictive risk factors of serious infections in patients with rheumatoid arthritis treated with abatacept in common practice: results from the Orencia and Rheumatoid Arthritis (ORA) registry.
Salmon JH, Gottenberg JE, Ravaud P, Cantagrel A, Combe B, Flipo RM, Schaeverbeke T, Houvenagel E, Gaudin P, Loeuille D, Rist S, Dougados M, Sibilia J, Le Loët X, Meyer O, Solau-Gervais E, Marcelli C, Bardin T, Pane I, Baron G, Perrodeau E, Mariette X; all the investigators of the ORA registry and the French Society of Rheumatology. Salmon JH, et al. Ann Rheum Dis. 2016 Jun;75(6):1108-13. doi: 10.1136/annrheumdis-2015-207362. Epub 2015 Jun 5. Ann Rheum Dis. 2016. PMID: 26048170
Non-TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug: A Randomized Clinical Trial.
Gottenberg JE, Brocq O, Perdriger A, Lassoued S, Berthelot JM, Wendling D, Euller-Ziegler L, Soubrier M, Richez C, Fautrel B, Constantin AL, Mariette X, Morel J, Gilson M, Cormier G, Salmon JH, Rist S, Lioté F, Marotte H, Bonnet C, Marcelli C, Sellam J, Meyer O, Solau-Gervais E, Guis S, Ziza JM, Zarnitsky C, Chary-Valckenaere I, Vittecoq O, Saraux A, Pers YM, Gayraud M, Bolla G, Claudepierre P, Ardizzone M, Dernis E, Breban MA, Fain O, Balblanc JC, Aberkane O, Vazel M, Back C, Candon S, Chatenoud L, Perrodeau E, Sibilia J, Ravaud P. Gottenberg JE, et al. Among authors: salmon jh. JAMA. 2016 Sep 20;316(11):1172-1180. doi: 10.1001/jama.2016.13512. JAMA. 2016. PMID: 27654603
Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study.
Darloy J, Segaud N, Salmon JH, Eschard JP, Goëb V, Deprez X, Guyot MH, Houvenagel E, Lecuyer N, Marguerie L, Gally S, Pau D, Idier I, Baudens G, Flipo RM. Darloy J, et al. Among authors: salmon jh. Rheumatol Ther. 2019 Mar;6(1):61-75. doi: 10.1007/s40744-018-0138-y. Epub 2019 Jan 10. Rheumatol Ther. 2019. PMID: 30632015 Free PMC article.
131 results